ASCENTA CAPITAL
Ascenta Capital is a private equity and venture capital firm.
ASCENTA CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2023-01-01
Status:
Active
Technology used in webpage:
Euro Google Maps Amazon CrUX Dataset Google Maps API Amazon Virginia Region CrUX Top 10m CloudFront COVID-19
Similar Organizations
AP Ventures
AP Ventures is an independent venture capital firm.
Evolution VC Partners
Evolution VC Partners is a venture capital firm.
Hanna Capital
Hanna Capital LLC engages in private equity and venture capital investing.
LDV Partners
LDV Partners is a Early Stage Investment Firm.
Leadout Capital
Leadout Capital is an early-stage venture capital fund.
NeptuneDAO
NeptuneDAO is a liquidity DAO for scaled yield.
Perwyn
Perwyn is an entrepreneurial, privately-funded investment firm.
The House Fund
The House Fund is a pre-seed and early stage venture capital fund focused on the boldest Berkeley startups.
WaterBridge Ventures
WaterBridge Ventures is an early stage venture capital firm.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2024-07-16 | Cardurion Pharmaceuticals | Ascenta Capital investment in Series B - Cardurion Pharmaceuticals | 260 M USD |
2023-12-05 | Odyssey Therapeutics | Ascenta Capital investment in Series C - Odyssey Therapeutics | 101 M USD |
2023-10-03 | Iambic Therapeutics | Ascenta Capital investment in Series B - Iambic Therapeutics | 100 M USD |
2023-08-09 | ADARx Pharmaceuticals | Ascenta Capital investment in Series C - ADARx Pharmaceuticals | 200 M USD |
2023-01-20 | ADARx Pharmaceuticals | Ascenta Capital investment in Series B - ADARx Pharmaceuticals | 46 M USD |
More informations about "Ascenta Capital"
Team - Ascentacap
He was a Principal at Bain Capital Ventures from 2012 to 2015, and began his career in New York City at McKinsey & Company and Pfizer. Evan currently serves on the board of directors of …See details»
Ascenta Capital - Crunchbase Investor Profile
Ascenta Capital invests in early to late-stage biotechnology and healthcare companies, focusing on the United States, particularly in California and Massachusetts.See details»
OUR TEAM — Ascenta Finance Corp
As the founder and President of Ascenta Finance Corp., Mr. Farris has participated in raising over $125 million in capital financing for public and private companies. Mr. Farris has completed the …See details»
Ascenta Finance Corp
Ascenta Finance Corp. is registered as an Exempt Market Dealer with the British Columbia, Alberta, Saskatchewan, Manitoba and Ontario Securities Commissions and is a member of the Private Capital Markets Association of Canada.See details»
Ascenta Capital - LinkedIn
Congratulations to Ascenta portfolio companies Cardurion Pharmaceuticals and Iambic Therapeutics for their inclusion in the 2024 Endpoints 11 List of Biotech's Most Promising Startups!See details»
Ascenta Capital - Investor Profile, Portfolio & Team - Tracxn
Jan 29, 2025 Ascenta Capital is a venture capital firm founded in 2023. It is primarily based out of New York City, United States. As of Oct 2024, Ascenta Capital is an active investor, having …See details»
Ascenta Capital investment portfolio | PitchBook
Founded in 2023, Ascenta Capital is a venture capital firm based in New York, New York The firm seeks to invest in the biotechnology sector.See details»
Ascenta Capital - Investments, Portfolio & Company Exits
Jan 20, 2023 Ascenta Capital has made 7 investments. Their most recent investment was on Oct 23, 2024, when Alpha9 Theranostics raisedSee details»
Ascenta Capital - life-sciences-usa.com
Jan 1, 2023 Ascenta Capital is a biotech-focused late-stage venture fund, co-founded in 2023 by Dr. Evan Rachlin and Dr. Lorence Kim. The fund is focused on concentrated investments in …See details»
John Gutierrez, MD - Ascenta Capital | LinkedIn
Experience: Ascenta Capital · Education: Columbia University Vagelos College of Physicians and Surgeons · Location: Miami · 500+ connections on LinkedIn. View John Gutierrez, MD’s profile on ...See details»
Ascenta Capital Fund I: Performance | PitchBook
General Information Description Ascenta Capital Fund I is a 2023 vinatge venture capital fund managed by Ascenta Capital. The fund is located in New York, New York. The fund targets the …See details»
Ascenta Capital Company Profile | Management and Employees …
Ascenta Capital Profile and History Ascenta Capital is a biotech-focused late-stage venture fund, co-founded in 2023 by Dr. Evan Rachlin and Dr. Lorence Kim. The fund is focused on …See details»
Ascenta Capital - Contacts, Employees, Board Members
Ascenta Capital is a private equity and venture capital firm.See details»
Ascenta Capital | Institution Profile | Private Equity International
Use Private Equity International's platform to access the latest news, analysis, insights and fund data for Ascenta Capital, as well as key contact information.See details»
Ascenta Capital - VC Firm Profile - Gaebler.com Venture Capital …
Ascenta Capital is a VC investing group investing in technology-based companies.See details»
Lorence Kim | Council Korean Americans (CKA)
Lorence Kim, M.D. is the co-founder and Managing Partner of Ascenta Capital, a biotech venture capital firm formed in 2022. Previously, he was a Venture Partner at Third Rock Ventures from …See details»
ASCENTA CAPITAL | Form ADV - Radient
Mar 29, 2024 Firm Details for ASCENTA CAPITAL, AUM = None, Last Form ADV Filed : 29-March-2024, Officers: ASCENTA CAPITAL MANAGEMENT, LLC, Rachlin, Evan, Lockwood, …See details»
Ascenta Capital Partners Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ascenta Capital Partners Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Ascenta Finance Corp Company Profile | Vancouver, BC, Canada ...
Find company research, competitor information, contact details & financial data for Ascenta Finance Corp of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Ascential Medical & Life Sciences Announces Executive Leadership ...
1 day ago Ellen Scipta and Chris Cowen join the organization as CFO and CCO, respectively, while Todd Martensen transitions from CCO to CSO SAN DIEGO, March 26, 2025 …See details»